Biolife Sciences (Biolife Sciences) LT-Debt-to-Total-Asset : 0.14 (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Biolife Sciences's long-term debt to total assests ratio for the quarter that ended in May. 2008 was 0.14.

Biolife Sciences's long-term debt to total assets ratio declined from May. 2007 (0.70) to May. 2008 (0.14). It may suggest that Biolife Sciences is progressively becoming less dependent on debt to grow their business.

Biolife Sciences LT-Debt-to-Total-Asset Historical Data

The historical data trend for Biolife Sciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences LT-Debt-to-Total-Asset Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

LT-Debt-to-Total-Asset

0.70

0.09

0.06

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial										0.70	0.11	0.06	0.05	0.14

Biolife Sciences LT-Debt-to-Total-Asset Calculation

Biolife Sciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Nov. 2007 is calculated as

LT Debt to Total Assets (A: Nov. 2007 )	=	Long-Term Debt & Capital Lease Obligation (A: Nov. 2007 )	/	Total Assets (A: Nov. 2007 )
	=	0.206	/	3.762
	=	0.05

Biolife Sciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in May. 2008 is calculated as

LT Debt to Total Assets (Q: May. 2008 )	=	Long-Term Debt & Capital Lease Obligation (Q: May. 2008 )	/	Total Assets (Q: May. 2008 )
	=	0.421	/	3.041
	=	0.14

Biolife Sciences (OTCPK:BLFE) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Biolife Sciences LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020